No, Foscarnet is NOT an Interferon
Foscarnet is an antiviral medication that works by directly inhibiting viral DNA polymerases, whereas interferons are immunomodulatory cytokines that work through completely different mechanisms.
Drug Classification and Mechanism
Foscarnet (Foscavir) is a pyrophosphate analog antiviral agent that selectively inhibits viral DNA polymerases at the pyrophosphate binding site 1. It does not require activation by cellular kinases and works by directly blocking viral replication 1.
In contrast, interferon-alfa is a naturally occurring cytokine that modulates immune responses and has hematologic, neurotoxic, and flu-like side effects 2. The evidence clearly distinguishes these as separate drug classes in treatment guidelines 2.
Clinical Uses Demonstrate Different Drug Classes
Foscarnet is used for:
- CMV retinitis and disseminated disease as an alternative to ganciclovir 2, 3
- Acyclovir-resistant HSV infections 2
- Administered intravenously at 60 mg/kg every 8 hours or 40 mg/kg three times daily 2
Interferon-alfa is used for:
- Hepatitis B and C treatment (often combined with ribavirin) 2
- Administered subcutaneously at 3 million units/m² three times weekly 2
Toxicity Profiles Are Completely Different
Foscarnet's major toxicities 2, 3:
- Nephrotoxicity (up to 30% of patients)
- Electrolyte abnormalities (hypocalcemia, hypophosphatemia, hypomagnesemia, hypokalemia)
- Requires dose adjustment for renal impairment
- Must be infused slowly over ≥2 hours with adequate hydration
Interferon-alfa's major toxicities 2:
- Hematologic toxicity (leukopenia, thrombocytopenia)
- Neurotoxicity (depression, confusion, insomnia)
- Flu-like syndrome (myalgia, fever, chills, headache)
- Dose-related effects that decrease over first 4 months
Common Pitfall to Avoid
The confusion may arise because both drugs can be used in HIV-infected patients with opportunistic infections, and they appear in the same treatment guidelines. However, they are never used interchangeably and have completely distinct mechanisms, indications, and toxicity profiles 2, 3.
One study even noted that concurrent administration of interferon-alpha with other antivirals like foscarnet may have prevented resistance development to foscarnet in HIV patients, demonstrating they work through complementary but different mechanisms 4.